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CORRESPONDING AUTHOR: M. ÜMİT UYAR (uyar@ccny.cuny.edu)
This work was supported in part by National Institutes of Health (NIH)-Research Centers in Minority Institutions program under
Grant 5G12MD007603, in part by the National Science Foundation (NSF) under Grant CNS-0619577, Grant ECCS-0421159,
and Grant IIP-1265265, in part by NHI-National Cancer Institute (NCI) under Grant U54CA132378, in part by the NIH-NCI
under Grant U54CA137788, in part by the NSF and NIH, and in part by the U.S. Army Communications-Electronics Research,
Development and Engineering Center (RD&E) under Contract W15P7T-09-CS021 and Contract W15P7T-06-C-P217.
ABSTRACT In evaluation of cell viability and apoptosis, spatial heterogeneity is quantified for cancerous
cells cultured in 3-D in vitro cell-based assays under the impact of anti-cancer agents. In 48-h experiments
using human colorectal cancer cell lines of HCT-116, SW-620, and SW-480, incubated cells are divided
into control and drug administered groups, to be grown in matrigel and FOLFOX solution, respectively. Our
3-D cell tracking and data acquisition system guiding an inverted microscope with a digital camera is utilized
to capture bright field and fluorescent images of colorectal cancer cells at multiple time points. Identifying the
locations of live and dead cells in captured images, spatial point process and Voronoi tessellation methods
are applied to extract morphological features of in vitro cell-based assays. For the former method, spatial
heterogeneity is quantified with the second-order functions of Poisson point process, whereas the deviation
in the area of Voronoi polygons is computed for the latter. With both techniques, the results indicate that
the spatial heterogeneity of live cell locations increases as the viability of in in vitro cell cultures decreases.
On the other hand, a decrease is observed for the heterogeneity of dead cell locations with the decrease in
cell viability. This relationship between morphological features of in vitro cell-based assays and cell viability
can be used for drug efficacy measurements and utilized as a biomarker for 3-D in vitro microenvironment
assays.
INDEX TERMS Cell viability, cell apoptosis, in-vitro cell based assays, morphological features, spatial
analysis methods, poisson point process, spatial heterogeneity, Voronoi tessellation, colorectal cancer cell
lines, FOLFOX treatment.
I. INTRODUCTION
Cell line and tissue based in-vitro cell culture systems are
tools to emulate in-vivo cell behavior and cellular inter-
actions [1]. With 3D cell culture assays, the physiologi-
cal relevance of in-vivo cell proliferation can be mimicked
while preserving cell viability and pathway activity [2]. Cell
viability, proliferation and morphology in 3D microenviron-
ment depend on administered drug in addition to the cell
line, matrix used to coat chamber slides and the structure of
assay [3]. Viability of incubated cells under the impact of
anti-cancer drugs and their morphology changes can be
observed via digitized microscopic images from cell cultures
captured during in-vitro experiments.
Poisson point process, a statistical tool for spatial analysis,
can be applied to captured images to characterize the patterns.
With distance-based techniques relying on the spacing of
the points and area-based methods evaluating the intensity
of observed numbers of points in predetermined subregions
(e.g., quadrats [4]), the variability in the point locations can
be analyzed to decidewhether a complete spatial randomness,
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a clustering or a regularity exists [5]. A homogenous process
is observed in the case of a complete spatial randomness,
whereas the distribution characteristic of points deviating
from a homogenous pattern is formed when an attraction or
an inhibition is present among points [6]. Ripley’s K-function
and its derived versions can be used to test the consistency of
observed patterns with a homogeneous Poisson process [7].
Voronoi tessellation is another spatial analysis tool for par-
titioning an Euclidian space into subregions based on node
locations, where an association of subregions of a given
plane to the closest nodes results in a tessellation diagram
containing information specific to a specific plane [8].
As part of our continuing research, we study growth and
shrinkage behavior of tumor mass in human body and in
xenograft models based on patient specific information such
as gene expressions and morphological features of tumor
tissue [9]–[11]. We compute tumor growth and shrinkage
for breast cancer patients using their MRI images of tumor
tissue and gene expression data [12]. To extract morpho-
logical features using spatial pattern analysis, we analyze
the digitized images of Hematoxylin & Eosin (H&E) slide
samples taken from mice models implanted with tumor spec-
imen of kidney cancer patients. In this paper, we examine
the relationship between cell viability and morphological
features of 3Dmicroenvironment using spatial analysis meth-
ods, namely poisson point process and Voronoi tessellations.
As case studies, we set up in-vitro experiments using human
colon carcinoma cell lines of HCT-116, SW-480 and SW-640.
The cells cultured in in-vitromicroenvironment were divided
into control and FOLFOX-administered groups for each exper-
iment. With our artificial intelligence based cell tracking and
data acquisition system [13], the bright field and fluorescent
images of predetermined locations of regions of interest (ROI)
are captured at certain time points to identify cell positions
in microenvironment and to evaluate viability. The morpho-
logical features are extracted for live and dead cell positions
separately to evaluate the heterogeneity of cell viability
and apoptosis, respectively. Using spatial point process and
Voronoi tessellations, we compute heterogeneity of the loca-
tions of cells administeredwith anti-cancer drugs.We observe
in all case studies that, due to the impact of FOLFOX solution,
while cell viability decreases in time, the heterogeneity of
live cell positions increases, whereas a decrease is noted for
the dead cell positions. The relationship between cell viabil-
ity and spatial heterogeneity among cell positions suggest
that they can be used for drug efficacy measurements and
utilized as a biomarker for 3D in-vitro microenvironment
assays. Preliminary versions of this work have been reported
in [14] and [15], where the morphological features of live and
dead cell positions were examined to evaluate the heterogene-
ity of cell viability and apoptosis.
Remainder of this paper is organized as follows. In Sec.II,
cell incubation process is presented. Our data acquisition
system is introduced in Sec. III. Spatial analysis tools to
compute morphological features of colorectal cells are for-
mulated in Sec. IV. The results for cell lines HCT-116, SW-480
and SW-620 are presented with three case studies in Sec. V.
Concluding remarks are in Sec. VI.
II. IN-VITRO CELL INCUBATION IN
3D MICROENVIRONMENT
In our in-vitro experiments, human colorectal cancer cell
lines of HCT-116, SW-620 and SW-480 were incubated on
75 cm2 cell culture flask using the process described in [16].
A matrigel matrix were used to incubate colorectal cells since
various signaling pathways controling cell motility and drug
sensitivity in cancer cells are activated by the components of
matrigel [17]. In this process, a matrigel basement membrane
matrix with a density of 2 mg/ml were used to coat chamber
slides. To provide the environment for matrigel polymeriza-
tion, chamber slides were then stored into an incubator of
37◦C for one hour. The cells were collected with trypsin and
counted by hemacytometer to add into chamber slides at a
density of 500, 000 cell/ml for the in-vitro experiments. The
cell suspension was combined with a media of FluoroBrite
DMEM to incubate with 10% of fetal Bovine serum, 5% of
penicillin and 5% CO2 at 37◦C for one day period to allow
their recovery from stress.
For prolonged cultured assays, cell viability reduces in
time due to the lack of oxygen and nutrients, and the accu-
mulation of waste [3]. In evaluation of the drug impact
on cell viability, the cancer cells cultured for experiments
were assigned into control and drug administered groups.
For the cancer cells which are under treatment, a FOLFOX
solution was prepared as a mixture of a concentration of
500 µM 5-Fluorouracil, 100 µM Leucovorin and 20 µM
Oxaliplatin [18]. Both FOLFOX solution and matrigel were
provided with Propidium Iodide which fluoresce in red at
535/617 nm excitation level to detect cell apoptosis with
its location. The experimental set up was put into special
portable incubator to keep the cells under required conditions
of 5% of CO2 and 37◦C .
III. 3D CELL TRACKING AND DATA ACQUISITION SYSTEM
In our study, using our 3D cell tracking and data acquisi-
tion system, which is built based on bio-inspired compu-
tation methods from our previous research [19], [20], we
observe the morphological changes in interest regions with
colorectal cancer cells and anti-cancer drugs. Our data acqui-
sition tool guides an imaging system of an inverted micro-
scope and a digital camera to record the bright field and
fluorescent images of the regions of interest at the desired
level of magnification during multi-day long experiments in
3D microenvironment.
To quantify the dependency between cell locations and
viability, we present three case studies, each set up as
a 48-hour experiment, where the images of colorectal cancer
cell lines HCT-116, SW-620 and SW-480 were captured at
every three hours. In Fig. 1, sample bright field and gray-
scaled fluorescent images which are captured for colorec-
tal cell line of HCT-116 at hours 0, 24 and 48 are shown.
In Fig. 1a, bright field images of control and treatment groups
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FIGURE 1. Bright field and gray-scaled fluorescent images of colorectal cell line HCT-116 from sample ROIs of control and
FOLFOX treated groups captured by an inverted microscope with 20X magnification at hour-0, hour-24, and hour-48
(Case Study-1). (a) Bright field image. (b) Fluorescent image.
are presented, where the morphological changes can be
observed as time progresses. The images in Fig. 1b illustrate
the locations of dead cells, which are marked with fluorescent
dyes. For each case study, time course of cell viability are
determined by calculating the number of incubated cells from
Fig. 1a and only the dead cells from Fig. 1b at multiple time
points.
IV. MORPHOLOGICAL FEATURES OF CELL CULTURES
Administering feature extraction methods on biological
images and their transforms, spatial properties of underly-
ing biological processes can be identified [21]. As part of
our ongoing research [9], we apply Voronoi tessellations to
pathology slide samples from kidney cancer xenograft mice
models to determine the features based on the nuclei locations
on slides. In another study [10], we have extracted spatial
randomness features from H&E slides to plug into our person-
alized relevance parameterization method to compute tumor
growth parameters. In this paper, we analyze the changes of
the morphological features in in-vitro 3D microenvironment
using the images captured by our data acquisition system at
certain time intervals. The relationship among the locations of
incubated cells administered with FOLFOX treatment is evalu-
ated with spatial analysis tools of poisson point process and
Voronoi tessellations. In addition to heterogeneity analysis,
these images are also evaluated to calculate cell viability
based on the ratio of the number of live cells to the number
of all incubated cells.
A. SPATIAL POINT PROCESS
Spatial poisson process describes the randomness and hetero-
geneity of points (i.e., events) statistically based on distances
as a similarity measurement among point locations [22].
Spatial randomness in point patterns can be interpreted with
the first and second order properties of poisson point process,
where the former is calculated to evaluate the variation among
point locations in large scale and the latter is to identify the
deviation tendency from a complete randomness of neighbor-
ing points in a local scale [23]. Quadrat count and kernel
estimation can be categorized as the first order properties,
while nearest neighbor functions can be defined as second
order properties [24].
The randomness in the distribution of biological cells can
be examined in terms of underlying Poisson process based
on their locations [25]. In this study, to evaluate the hetero-
geneity among neighboring cell positions, we compute the
functions of the second order properties using their spatial
proximity. The distance between a cell pair of ρi and ρj
is calculated using Minkowski distance function δk (ρi, ρj),
which can be formulated in a D dimensional space as








where k is the value of distance metric. Due to the fact that
two-dimensional images are captured from the microenvi-
ronment, spatial heterogeneity is calculated for an Euclidian
plane (i.e.,D = 2)with an Euclidian distancemetric of k = 2.
For a selected cell, its distance to every other cell is calculated
to identify the neighboring cells. For a given nearest neighbor
circle with a radius of υ, K − function ([4], [26]) can be










w(ρi, ρj)−1 · 1[δk (ρi,ρj)≤υ] (2)
where A is the area of the image andw(ρi, ρj) is the parameter
defined to eliminate the edge effect for a cell pair of ρi and
ρj [26]. Since the images captured from in-vitro microenvi-
ronment have straight boundaries, K-function is calculated
with the assumption of w(ρi, ρj) = 1. The indicator function
is defined for the range of
[
δk (ρi, ρj) ≤ υ
]
, which implies
that the summation in Eq. (2) is applied for the point pairs
whose Euclidian distance is smaller than the selected nearest
neighbor radius υ.
In the case of a complete spatial randomness (i.e., homoge-
nous point process), the value isK (υ) defined asπ · υ2 for the
expected number of observations in a neighboring region of
radius υ [4]. To determine how clustered or regular the point
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pattern is, the standardized version of K function, defined as






where L(υ) function has a positive value if there is an attrac-
tion among points, which results in a clustered point pattern,
whereas a negative value is calculated for L(υ) in the case of
a regular distribution due to the inhibition among points.
We define two types of events, based on live and dead
cell positions, for spatial heterogeneity analysis in in-vitro
microenvironment. To quantify the heterogeneity among
these event locations, where live cells are located and cell
apoptoses are occurred, we compute the second order prop-
erties of spatial pattern analysis. The relationship between
cell viability and spatial heterogeneity among event loca-
tions is examined for the cells cultured in FOLFOX solution.
First, the bright field and fluorescent images captured by our
3D cell tracking system are processed to identify the cell
locations from drug administered group at each time point
(e.g., every three hours). In this process, the heterogeneity of
a selected image can be quantified based on its deviation from
L − function for a set of radius values. For this purpose,
we define set SR with nearest neighbor radius values for an
Euclidian planar region R as {υi : υi = τ ∗ i + `, ∀i ∈ N },
where ` specifies the smallest radius and τ is the step size
between consecutive radius values from set SR. Using set SR,
heterogeneity is quantified with the definition of DL function







where the weight function ξ (υi) is defined as 1+ (υi− `)/rυ
to normalize the effect of radius. Here, rυ is the range of
radius values (i.e., rυ = υmax − `), and ξ (υi) ∈ [1 2]. In this
study, DL(R) is computed to evaluate spatial heterogeneity
of the images captured from in-vitro microenvironment with
colorectal cancer cells.
B. VORONOI TESSELLATIONS
Morphological features of digitized images captured from in-
vitro microenvironment at regular intervals can be identified
using Voronoi tessellations [27]. A Voronoi tessellation is
the partitioning of an Euclidian planar region into subregions
based on the node locations with respect to each other [8].
To build a Voronoi tessellation diagram, we first define set
MR for a planar region R, consisting of all pixel points of a
captured image and set P for the location of cells observed in
region R. The closest cell to a pixel point µi from setMR can
be calculated as:
f (µi) = argmin
ρj∈P
δk (µi, ρj) (5)
where δk (µi, ρj) is the distance between point µi and the
cell ρj, formulated in Eq. (1), and the distance metric is set as
k = 2. Once every point µi of planar region R is associated to
the closest cell ρj, Voronoi polygon Vj corresponding to the
cell ρj can be stated as:
Vj = {µi ∈ MR : f (µi) = ρj,∀ρj ∈ P} (6)
In our study, for spatial pattern analysis, we construct Voronoi
tessellation diagrams based on two different cases, the loca-
tions of live cells and cell apoptosis positions. We calculate
the deviation among polygon areas to determine the charac-
teristics of the cell positions cultured in in-vitro microenvi-
ronment under FOLFOX treatment.
C. SPATIAL PATTERN ANALYSIS OF
3D MICROENVIRONMENT
The locations of cells cultured in in-vitro microenvironment
are evaluated to apply spatial point process and Voronoi
tessellations. In Fig. 2, the process to generate diagrams
for spatial analysis methods is illustrated for samples of
bright field and fluorescent images captured at hour 24 from
a selected region of interest (ROI) of the experiment with
HCT-116 cell line. To generate the binary images, the bright
field and the gray-scaled fluorescent images, shown in
Figs. 2a and 2b respectively, are processed using binary
imaging and image morphology operations such as image
filtering, image dilation and erosion. In Figs. 2c and 2d, the
binary images corresponding to the bright field (in Fig. 2a)
and fluorescent (in Fig. 2b) images are presented for the
selected ROI from HCT-116.
We implemented software to identify the live and dead cell
locations using binary images and to generate their Voronoi
tessellations. To illustrate this process, let us consider the
selected ROI shown in Fig. 2. First, with the image given
in Fig. 2c the locations of all cells are identified. Similarly,
binary version of the fluorescent image in Fig. 2d is analyzed
to determine the set of dead cell locations. Then, the set of
dead cells is subtracted from the set of all cell locations to
obtain the live cell locations. Fig. 2e shows both the live
and dead cell locations for the selected ROI. The dead cell
locations generated by our software are in Fig. 2f. As the last
step, our software generates the Voronoi tessellation diagrams
for the live and dead cells, as shown in Figs. 2g and 2h,
respectively, for the same ROI.
To examine the existence of dependency among incubated
colorectal cancer cell positions, we compute the heterogene-
ity of their locations using poisson point process methods.
We determine the smallest and the largest nearest neighbour
radius values based on the locations of the live and dead
cells observed in all images taken during experiments. The
smallest circle is selected for all images such that at least
one live cell is in the circle for all live cells, while the
largest circle is reached when the increase in the radius value
does not change the trend in L function for all live cells
for all images. In Fig. 3a, a region taken from Fig. 2e is
shown with the smallest and the largest circles for a single
selected live cell marked at the center. Fig. 3b gives the trend
of L-function, formulated by Eqs. (1) to (3), for the image
in Fig. 2e. Here, the magnitude of L-function corresponds
4300209 VOLUME 4, 2016
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FIGURE 2. Spatial pattern analysis process for sample images captured
from FOLFOX administered HCT-116 cells at hour 24 in Case Study I.
(a) Sample bright field image. (b) Sample fluorescent image.
(c) Binary image of sample in (a). (d) Binary image of sample
in (b). (e) Live and dead cell positions of sample in (a). (f) Dead
cell positions of sample in (b). (g) Voronoi tessellations of live
cells in (e). (h) Voronoi tessellations of dead cells in (f).
FIGURE 3. (a) A region taken from the image in Fig. 2e showing the
smallest (υ = 60 pixels) and largest (υ = 160 pixels) nearest neighbour
circles for a single selected live cell (marked in purple at the center),
(b) L-function computed for radius values for all live cells in Fig. 2e.
to the deviation from complete spatial randomness. In our
study, we repeat this process for all images collected from
in-vitro microenvironment. With the L-function values,
we then compute DL function values, using Eq. (4), for the
images captured at different time points.
In another approach to evaluate spatial heterogeneity
among the cell locations, we compute the deviation among
the area values of Voronoi polygons as a heterogeneity
metric. A large deviation implies heterogenous distribution
of cells, whereas a small deviation points out a homogeneity
among cell positions. For the tessellation diagram given in
Fig. 2g, the distribution function of the polygon area values
is presented in Fig. 4. Their mean value and the standard
deviation are calculated as 0.43× 104 and 0.29× 104 pixels,
respectively.
FIGURE 4. Histogram of the Voronoi polygon area for the tessellation
diagram in Fig. 2g with a mean value of 0.43 · 104 and a standard
deviation of 0.29 · 104 pixels.
Using the results from both spatial analysis methods, we
quantify the relationship between cell viability and spatial
heterogeneity for the cell lines HCT-116, SW-620 and SW-480,
as presented in Sec. V.
V. ANALYTICAL RESULTS OF IN-VITRO MEASUREMENTS
To study the relationship between cell viability and spatial
heterogeneity in the positions of cancer cells, we present three
case studies using colorectal cancer cell lines of HCT-116,
SW-620 and SW480. For each case study, the cells are divided
into drug-free control and anti-cancer treatment groups.
Control group of colorectal cancer cells are cultured in
metragel, whereas the cells of the treatment group are in
FOLFOX solution, and both are provided with nutrition and gas
supplies at an ideal temperature of 37◦C for 48 hours.
For cell viability evaluation in our 48 hour long experi-
ments, eight regions of interest ROIs are randomly selected
for each group. Our data acquisition system tracks the posi-
tions of these selected ROIs to capture their bright field and
fluorescence dyed images at predetermined intervals (every
three hours for this study). Our system is capable of auto-
matically identifying the ROIs at each time point and placing
the microscope lens at their central positions, and therefore,
maintaining visual focus and tracking the cell clusters in
3D microenvironment throughout the experiments.
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The ROI size is determined based on the number of cells
located in a selected region. In our experiments, we obtain
statistically meaningful results when the images are cap-
tured with 20X magnification. For example, with a higher
level of magnification (e.g., 40X), the average number of
cells observed in selected ROIs was less than 10. The cells
within the selected ROI can be seen in the bright field images
of Figs. 1 and 2.
At each time point, the number of cells are calculated
using the images captured from control and FOLFOX-treated
groups. The spatial heterogeneity is computed based on the
locations of live and dead cells, which are identified from the
bright field and fluorescent images, respectively. In Fig. 5,
cell viability is presented for the colorectal cancer cell lines of
HCT-116, SW-620 and SW480. For each case study, left vertical
FIGURE 5. Number of cells and normalized cell viability from
experimental measurements for colorectal cell lines HCT-116 in (a),
SW-620 in (b) and SW-480 in (c).
axis is scaled to present the total number of live and dead
cells for the FOLFOX-treated groups with green and pink bars,
respectively. The normalized values of cell viability for the
control groups are given with gray-colored bars, which are
scaled with respect to the right vertical axis of Fig. 5. For
all experiments, since the ROIs were randomly identified at
the beginning of each experiment, a high value of standard
deviation in the number of live cells is observed in Fig. 5,
implying that the number of cells in the selected regions vary
significantly with respect to each other.
In our case studies, we have examined spatial heterogene-
ity for the locations of live and dead cells from the drug
administered groups. For live cell positions, heterogeneity
is evaluated for the normalized viability levels of ν = 0.9,
0.8 and 0.7, corresponding to the time points at which 90%,
80% and 70% of the cells are alive, respectively, as the
impact of FOLFOX solution increases. In Fig. 6, the results
of spatial point process and Voronoi tessellations are given
for the live cell positions. For the morphology analysis of
in-vitro cell-based assays with respect to the dead cell loca-
tions, the viability levels are selected as ν = 0.8, 0.7 and
0.6. The spatial heterogeneity results of dead cell locations
are presented in Fig. 7.
A. CASE STUDY I: HCT-116 COLORECTAL CELL LINE
In this case study, cancer cells from colorectal cell line of
HCT-116 were cultured in in-vitro microenvironment. Cell
viability and the number of cells were evaluated at every three
hours during the 48-hour long experiment. As can be seen in
Fig. 5a, the number of live cells start decreasing at hour 15
with the impact of the anti-cancer drug. At hour 48, we have
measured that the number of dead and live cells are almost
equal to each other, implying that approximately 50% of cells
were dead at the end of the experiment.
For colorectal cell line of HCT-116, we compute spatial het-
erogeneity among live cell positions at hours 18, 24 and 30,
corresponding to the viability of 0.9, 0.8 and 0.7, respectively.
The normalized non-randomness values from spatial point
process are given in Fig. 6a. For the same selected ROIs, the
deviation among the Voronoi polygon areas is presented in
Fig. 6d. With both methods, an increasing trend is observed
for the heterogeneity among live cell positions in eight ROIs.
Using spatial point process and Voronoi tessellations, the het-
erogeneity among dead cell locations is evaluated as shown in
Figs. 7a and 7d, respectively. For both methods, we have ana-
lyze the results for the images captured at hours 24 (ν = 0.8),
30 (ν = 0.7) and 39 (ν = 0.6). Similar to the results
obtained for live cells, a relationship between the morpholog-
ical features of dead cells and cell viability is observed such
that heterogeneity of the dead cell positions has a decreasing
behaviour with the decrease in viability.
B. CASE STUDY II: SW-620 COLORECTAL CELL LINE
The characteristic of cell line SW-620 obtained from human
colon lymph node tissue were evaluated in a 48-hour experi-
ment. In Fig. 5b, we observe that the cells are more resistant
4300209 VOLUME 4, 2016
Saribudak et al.: Spatial Heterogeneity Analysis in Evaluation of Cell Viability and Apoptosis
FIGURE 6. Normalized heterogeneity results among live cell positions: (a), (b) and (c) are from spatial point process, for colorectal cell lines HCT-116,
SW-620 and SW-480, respectively, all are under FOLFOX treatment; (d), (e) and (f) are from deviation results among Voronoi polygon areas for
colorectal cell lines HCT-116, SW-620 and SW-480, respectively; all are under FOLFOX treatment.
FIGURE 7. Normalized heterogeneity results among dead cell positions: (a), (b) and (c) are from spatial point process, for colorectal cell lines HCT-116,
SW-620 and SW-480, respectively, all are under FOLFOX treatment; (d), (e) and (f) are from deviation results among Voronoi polygon areas for
colorectal cell lines HCT-116, SW-620 and SW-480, respectively, all are under FOLFOX treatment.
to anti-cancer agents as a high value of viability remains
until hour 24, after which point the viability starts decreasing
gradually. At the end of the 48 hour long experiment, the
viability is observed as 0.6 as presented in Fig. 5b.
The heterogeneity of the cell positions is computed for
hours 27, 36, 42 and 48 corresponding to the viability levels of
ν = 0.9, 0.8, 0.7 and 0.6, respectively. For the live cells of the
FOLFOX treated group, non-randomness values are shown in
Fig. 6b for the selected ROIs. Fig. 6e illustrates the heterogene-
ity results computed based on the deviation among Voronoi
polygon areas. Similar to the case of cell line HCT-116,
we observe an increase in the heterogeneity of live cells as the
viability decreases. Figs. 7b and 7e show the results of spatial
analysis methods for the dead cell locations. Even though the
impact of anti-cancer drug for cell line SW-620 is not as strong
as it is for the cell line HCT-116, a similar relationship as in
VOLUME 4, 2016 4300209
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Case Study I is observed between spatial heterogeneity of
dead cells and cell viability.
C. CASE STUDY III: SW-480 COLORECTAL CELL LINE
The colorectal cell line SW-480 of adenocarcinoma cells are
incubated in 3D microenvironment for this case study. The
number of live and dead cells from the treatment group and
the viability measured for the control group are illustrated
in Fig. 5c. Different than the observations for the cell lines
HCT-116 and SW-620, the anti-cancer solution has a quick
impact on the viability for cell line SW-480. The viability
starts decreasing at around hour 9 as shown in Fig. 5c with
the bars colored in green and pink for the number of cells.
However, drug impact on live cells saturates at a certain time
point when the viability was measured as ν = 0.6. For
cell line SW-480, it can be concluded that the cells are less
resistant to anti-cancer treatment especially during the initial
phase of the drug administration.
The results from spatial heterogeneity methods are shown
in Figs. 7c and 7f for cell line SW-480. The spatial analysis
methods are measured at hours 9 (ν = 0.9), 15 (ν = 0.8),
24 (ν = 0.7) and 36 (ν = 0.6). An increasing trend is
observed for the heterogeneity of the live cell positions with
a decrease in cell viability, whereas both spatial point pro-
cess and Voronoi tessellations generate heterogeneity results
decreasing with smaller cell viability values for dead cells.
VI. CONCLUDING REMARKS
In this paper, we examine a relationship between cell viability
and the spatial heterogeneity of the locations of live and
dead cells incubated in 3D in-vitro cell-based assays under
the impact of anti-cancer agents We set up three 48-hour
long experiments using human colorectal cancer cell lines of
HCT-116, SW-620 and SW-480. With our 3D cell tracking and
data acquisition system guiding an inverted microscope with
a digital camera, were able to capture bright field and fluo-
rescent images of colorectal cancer cells at pre-determined
intervals during the experiments. After the locations of live
and dead cells in captured images are identified, Poisson
point process and Voronoi tessellation methods are applied
to extract their morphological features. The spatial analysis
results obtained in all case studies for both live and dead cells
points out that there is a relationship between cell viability
and heterogeneity among cell positions. We observe that
heterogeneity of live cell locations increases as the number
of live cells in microenvironment decreases under the impact
of anti-cancer drugs. For cell apoptosis, our analysis indicate
that the randomness in dead cell locations increases as the
cell viability in in-vitro cell cultures decreases. Similarly,
a decrease in deviation of Voronoi polygon areas for the
dead cells is observed as the experiments progress under
the impact of anti-cancer drugs. This relationship between
morphological features of in-vitro cell based assays and cell
viability can be used for drug efficacy measurements and
utilized as a biomarker for 3D in-vitro microenvironment
assays.
As future direction, we plan to extend this study to include
different human carcinoma including breast and kidney can-
cers with additional clinical measurements such as blood
serum samples and genetic information.
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